Sign In
NewsRadar

Vivet Therapeutics

Vivet Therapeutics is developing gene therapy treatments for rare, inherited metabolic diseases. It is building a pipeline based on Adeno Associated Virus (AAV) technologies. Vivet's lead program, VTX801, is an investigational gene therapy for Wilson disease. This rare genetic disorder is caused by a defective gene in liver cells encoding the ATP7B protein, which reduces the liver's ability to regulate copper levels in the liver and other tissues.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Web:
Contact:
 
 
29 rue Tronchet
Paris 75008
France
+33-684-755-087
http://www.vivet-therapeutics.com
Jean-Philippe Combal
+33-684-755-087

Company Facts
Founded:
Founders:
CEO:Jean-Philippe Combal
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


23,644
Tech investments
From our Online Data Service
15,269
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 6€5.0MIT services
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.